12:00 AM
Oct 01, 2012
 |  BC Week In Review  |  Company News  |  Deals

Pulmagen, Teijin deal

Pulmagen granted Teijin exclusive rights to develop and commercialize ADC3680 in Japan. Teijin plans to start Phase...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >